Vermont Healthcare: IV Antibiotic Labeling Errors - CA

Healthcare Facility:

TORRANCE, CA - Federal inspectors cited Vermont Healthcare Center for critical medication safety violations after discovering IV antibiotic labels that didn't match physician orders, affecting multiple residents and creating significant risks for dangerous medication errors.

Vermont Healthcare Center facility inspection

![Vermont Healthcare Center exterior](image-placeholder.jpg)

Advertisement

IV Antibiotic Labeling Failures Discovered

During a March 14, 2025 inspection, surveyors found that 100% of sampled IV antibiotic administrations had incorrect labeling. Two residents receiving the critical antibiotic Zosyn (piperacillin sodium-tazobactam sodium) had medication labels that didn't correspond to their physician orders.

Resident 22 was receiving Zosyn labeled as "3.375 gram in 100 milliliter of 0.9% sodium solution," but the physician order specified the medication should be prepared "in dextrose 3-0.375 gm/50ml." The discrepancy involved both the diluent solution (normal saline versus dextrose) and the volume (100ml versus 50ml).

Similarly, Resident 44's Zosyn medication label didn't match the physician's order. During the inspection, Registered Nurse 4 acknowledged that "the label on Resident 44's Zosyn did not match with Resident 22's physician order" - indicating staff awareness of the labeling problems.

Critical Nature of IV Antibiotic Administration

IV antibiotics like Zosyn are prescribed for serious infections including urinary tract infections and pneumonia. The medication must be prepared and administered exactly as ordered because incorrect concentrations, diluents, or infusion rates can lead to treatment failure or adverse reactions.

Proper labeling ensures that nurses can verify they're administering the correct medication, concentration, and preparation method. When labels don't match physician orders, it creates confusion about what the patient is actually receiving and whether the preparation matches medical requirements.

The facility's own Medication Administration Policy states that "medications must be administered in accordance with the orders including any required time frame," highlighting the importance of accurate labeling and administration.

Thyroid Medication Administration Concerns

Inspectors also identified issues with thyroid medication administration for Resident 361, who has hypothyroidism and requires daily thyroid hormone replacement therapy. The resident told inspectors: "she does not always receive her thyroid medications in the morning" as prescribed.

Review of medication records revealed missed doses of Liothyronine on March 1 and March 6, 2025. The assigned Licensed Vocational Nurse acknowledged missing the medication on March 6, stating she "was not sure how she missed that medication."

Thyroid medications must be taken consistently and typically in the morning for optimal absorption. The nurse recognized that "missing doses of thyroid medications can result in constipation and hypothyroidism," indicating awareness of the clinical consequences.

Medical Standards and Best Practices

Federal regulations require that nursing homes ensure all medications are properly labeled according to accepted professional standards and administered as ordered by physicians. This includes having accurate information about drug names, concentrations, diluents, and administration instructions.

For IV medications, proper labeling is particularly critical because these drugs bypass normal absorption processes and go directly into the bloodstream. Any errors in preparation or identification can have immediate effects on patient safety.

Thyroid hormone replacement requires consistent daily administration because these hormones regulate metabolism throughout the body. Missed doses can lead to symptoms including fatigue, depression, weight gain, and cardiovascular complications in patients with existing heart conditions.

Facility Response and Oversight

The violations were classified as having "minimal harm or potential for actual harm" but affecting multiple residents. The IV labeling issue was noted to have "potential for medication error," while the thyroid medication problem affected "many" residents according to the inspection report.

Vermont Healthcare Center, located at 22035 S. Vermont Avenue in Torrance, must submit a plan of correction addressing these medication administration and labeling deficiencies. The facility serves residents with complex medical conditions requiring precise medication management.

Regulatory Context

These violations fall under federal nursing home regulations F760 and F761, which govern medication administration accuracy and proper drug labeling and storage. Federal inspectors conduct regular surveys to ensure facilities meet safety standards for vulnerable elderly and disabled residents.

Medication errors in nursing homes can have serious consequences because residents often have multiple medical conditions and take numerous medications. Proper administration protocols and accurate labeling serve as critical safety measures to prevent harmful interactions and ensure therapeutic effectiveness.

The inspection findings highlight the importance of staff training, clear procedures, and quality assurance measures in medication management systems at long-term care facilities.

Full Inspection Report

The details above represent a summary of key findings. View the complete inspection report for Vermont Healthcare Center from 2025-03-14 including all violations, facility responses, and corrective action plans.

Additional Resources